Evaluation of some pharmacological activities of ethanol extracts of seeds, pericarp and leaves of Eugenia Jamolana in rats

Inflammopharmacology

Volumn 17, Issue 2, 2009, Pages 85-92

  El Shenawy, S M A ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

CCL 4; E. Jamolana; GSH; Inflammation; Leaves; Liver enzymes; MDA; Pericarp; Rats; Seeds; Ulcer

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CARRAGEENAN; ELLAGITANNIN; EPICO; EUGENIA JAMOLANA EXTRACT; GLUTATHIONE; INDOMETACIN; LIPID PEROXIDE; PLANT EXTRACT; SILYMARIN; TANNIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; ENZYME BLOOD LEVEL; EUGENIA; EUGENIA JAMOLANA; FEMALE; INFLAMMATION; LD 50; LIVER PROTECTION; MALE; NONHUMAN; PAW EDEMA; PERICARP; PLANT LEAF; PLANT SEED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STOMACH PROTECTION; STOMACH ULCER;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; ETHANOL; EUGENIA; FEMALE; HEPATITIS, TOXIC; LETHAL DOSE 50; LIVER FUNCTION TESTS; MALE; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, SPRAGUE-DAWLEY; SEEDS; STOMACH ULCER;

EID: 64049091654     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-008-8034-7     Document Type: Article

References (50)

1. Ali B. H, Bashir A. K., Rasheed R. A. (2001). Effect of the traditioal medicinal plants Rhaza stricta, Balanitis aegytiaca and Haplophylum tuberculatum on paracetamol-induced hepatotoxicity in mice. J. phgtother. Res. 15(7), 598-603.
2. Armitage P. (1971). Statistical Methods in Medical Research, John Wiley, New York.
3. Babu P. S., Stanely Mainzen Prince P. (2004). Antihyperglycaemic and antioxidant effects of hyponidd, an ayurvedic herbomineral formulation in streptozotocin-induced diabetic in rats. J. Pharm. Pharmacol. 56(11), 1435-42.
4. Baily L. H. 1. (1958). Manual of cultivated plants, revised Edition 724-31, Macmillan Company, New York.
5. Bass N. M. (1999). Is there any use for nontraditional or alternative therapies in patients with chronic liver disease? Curr. Gastroenterology Rep 1, 50-6.
6. Beutler E., Duron O., Kelly B. M. (1963). Improved method for the determination of blood glutathione. J. Lab. & Clin. Med., 61-5.
7. Chaieb K., Zmantar T., Ksouri R., Hajlaoui H., Mahdouani K., Abdelly C., Bakhrouf A. (2007). Antioxidant properties of the essential oil of Eugenia caryophyllata and its antifungal activity against a large number of clinical Candida species. Mycoses. 50(5), 403-6.
8. Chandrasekaran M., Venkatesalu V. (2004). Antibacterial and antifungal activity of Syzygium jambolanum seeds. J. Ethnopharmacol. 91(1), 105-8.
9. Chaudhuri N., Pal A. K., Gomes S., Bhattacharya A. (1990). Anti-inflammatory and related action of Syzygium cumini seed extract. Phytotherapy research. 4 (1), 5-10.
10. Crunkhon P., Meacok S. E. R. (1971). Mediators of the inflammation induced in the rat paw by carrageenan. Br. J. Pharmacol. 42, 392-402.
11. de Souza G. C., Haas A. P., Von Poser G. L., Schapoval E. E., Elisabetsky e. (2004). Ethnopharmacological studies of antimicrobial remedies in the south of Brazil. J. Ethnopharmacol. 90(1), 135-43.
12. DiRosa M., Giroud J. P., Willoughby D. A. (1971). Studies of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J. of Pathology 104, 15-29.
13. Djoukeng J. D., Abou-Mansour E., Tabacchi R., Tapondjou A. L., Bouda H., Lontsi D. (2005). Antibacterial triterpenes from Syzygium guineense (Myrtaceae). J. Ethnopharmacol. 3, 101(1-3), 283-6.
14. Jagetia G. C., Baliga M. S. (2004). The evaluation of nitric oxide scavenging activity of certain Indian medicinal plants in vitro: a preliminary study. J. Med. Food. 7(3), 343-8.
15. Jirovetz L., Buchbauer G., Stoilova I., Stoyanova A., Krastanov A., Schmidt E. (2006).Chemical composition and antioxidant properties of clove leaf essential oil. J. Agric. Food Chem. 54(17), 6303-7.
16. Li Y., Xu C., Zhang Q., Liu J. Y., Tan R. X. (2005). In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicines used to treat ulcer diseases. J. Ethinopharmacol. 26, 98(3), 329-33.
17. Mahmoud I. I., Marzouk M. S, Moharram F. A., El-Gindi M. R., Hassan A. M. (2001). Acylated flavonol glycosides from Eugenia Jamolana leaves. Phytochemistry. 58(8), 1239-44.
18. Mallick C., Mandal S., Barik B., Bhattacharya A., Ghosh D. (2007). Protection of testicular dysfunctions by MTEC, a formulated herbal drug, in streptozotocin induced diabetic rat. Biol Pharm. Bull. 30(1), 84-90.
19. Mózsik G. Y., Móron F., Javor T. (1982). Cellular mechanism of the development of gasric mucosal damage and gastric cytoprotection induced by prostacyclin in rats. A pharmacological study. Prostaglandins Leukot. Med., 71-84.
20. Marzouk M. S. A., El-Tooumy S. A. A., Moharram F. A., Shalaby N. M. M., Ahmed A. A. E. (2002). Pharmacologically active ellagitannins from Terminalia myriocarpa. Planta Med 69, 523-7.
21. Miyazawa M., Hisama M. (2003). Antimutagenic activity of phenylpropanoids from clove (Syzygium aromaticum). J. Agric. Food Chem. 22, 51(22), 6413-22.
22. Mukherjee P. K., Saha K., Murugesan T., Mandai S. C., Pal M., Saha B. P. (1998). Screening of antidiarrhoeal profile of some plant extracts of a specific region of West Bengal India. Journal of Ethnopharmacology 60, 85-89.
23. Muruganandan S., Pant S., Srinivasan K., Chandra S., Tandan S. K., Lal J, Prakash R. V. (2002). Inhibitory role of Syzygium cumini on autacoids-induced inflammation in rats. Indian J. Physiol. Phharmacol. 49(4), 482-6.
24. Muruganandan S., Srinivasan K., Chandra S., Tandan S. K., Lal J., Raviprakash V. (2001). Anti-inflammatory activity of Syzygium cumini bark. Fitoterapia. 72(4): 369-75.
25. Muruganandan S., Srinivasan K., Tandan S. K., Jawaharlal S. C., Raviprakash V. (2000). Anti-inflamatory and analgesic activities of some medicinal plants. J. Med. Aromat. Plant. Sci. 22(4A)-23(A), 56-8.
26. Obukowicz M. G., Welsch D. J. Salsgiver W. J., Martin-Berger, Chinn K. S., Duffin K. L. (1998). Novel selective 6 or 5 fatty acid desaturase inhibitors as anti-inflammatory agents in mice. J Pharmacol. Exp. Ther. 287, 157-66.
27. Oliveira A. C. P., Endringer D. C., Amorim L. A. S, Das Gracas M., Brandao M. D. G, Coelho M. M. (2005). Effect of the extracts and fractions of Baccharis trimera and Syzygium cumini on glycaemia of diabetic and non-diabetic mice. J .Ethnopharmacol. 1, 102(3), 465-9.
28. Radwan A. G. (1967). Studies on histamine metabolism in the rat. Ph. D. Thesis in Pharmacology, London University.
29. Ramirez R. O., Roa C. C. Jr (2003). The gastroprotective effect of tannins extracted from duhat (Syzygium cumini Skeels) bark on HCl/ ethanol induced gastric mucosal injury in Sprague-Dawley rats. Clin. Hemorheol. Microcirc. 29(3-4), 253-61.
30. Ravi K., Sekar D. S., Subramanian S. (2004). Hypoglycemic activity of inorganic constituents in Eugenia Jamolana seed on streptozotocin-induced diabetes in rats. Biol. Trace. Elem. Res. 99(1-3), 145-55.
31. Ravi K., Sivagnanam K., Subramanian S. (2004). Anti-diabetic activity of Eugenia Jamolana seed kernels on streptotocin-induced diabetic rats.J. Med. Food 7(2), 187-91.
32. Reitman S., Frankel S. (1957). Calorimetric method for asparate and alanine amino transferses. Am. J.Clin. Path. 28, 56-63.
33. Sagrawat H., Mann A. S., Kharya M. D. (2006). Pharmacological potential of Eugenia Jamolana: A review. Pharmacognosy Magazine. 6, 96-105.
34. Semler D. E. (1992). The Rat toxicology in: Animal Models In Toxicology Gad S. C. & Chengelis C. P. (Eds), P 39, Marcel Dekker, Inc., New York, Basel, and Hong Kong.
35. Sendocor W. G., Cochran G. W. (1971). Statistical methods. University Press, Loma State Ames.
36. Sharma S. B., Nasir A., Prabhu K. M., Murthy P. S. (2006). Antihyperglycemic effect of the fruit-pulp of Eugenia Jamolana in experimental diabetes mellitus. J. Ethnopharmacol. 104(3), 367-73.
37. Shekelle P. G., Hardy M., Morton S. C., Coulter I., Venuturupalli S., Favreau J., Hilton L. K. (2005). Are Ayurvedic herbs for diabetes effective? J. Fam. Pract. 54(10), 876-86.
38. Silva D. H. S., Plaza C. V, Bolzani V. da S., Cavalheiro A. J., Castro-Gamboa I. (2006). Antioxidants from fruits and leaves of Eugenia Jamolana, an edible Myrtaceae species from Atlantic Forest.Plantao Med. 72.
39. Sorg D. A., Buckner B. A. (1964). Simple method of obtaining venous blood from small animals. Proc. Sec. Exp. Med. 115, 1131-2.
40. Sridhar S. B., Sheetal U. D., Pai M. R., Shastri M. S. (2005). Preclinical evaluation of the antidiabetic effect of Eugenia Jamolana seed powder in streptozotocin-diabetic rats. Braz. J. Med. Biol. Res. 38(3), 463-8.
41. Stanely M. P. P., Kamalakkannan N., Menon V. P. (2003). Syzigium cumini seed extracts reduce tissue damage in diabetic rat brain. J. Ethnophrmacol. 84(2-3), 203-9.
42. Tajuddin, Ahmed S., Latif A., Qasmi I. A. (2003). Aphrodisiac activity of 50% ethanolic Extracts of Myristicafragrans Hott.(Nutmeg) and Syzgium aromaticum (L) Merr. & Perry. (Clove) in mal mice: a coparative study. BMC Complement Altern. Med. 20, 3-6.
43. Teixeira C. C., Fuchs F. D. (2006). The efficacy of herbal medicines in clinical models: the case of jambolan. J. Ethnopharmacol. 108(1), 16-9.
44. Teixeira C C., Fuchs F. D., Weinert L. S., Esteves J. (2006). The efficacy of folk medicines in the management of type 2 diabetes mellitus: results of a randomized controlled trial of Syzygium cumini (L.) Skeels. J. Clin. Pharm.Ther. 31(1), 1-5.
45. Tiez N. W., Shuey D. F. (1986). Reference intervals for alkaline phosphatase activity determination by IFCC and AACC reference methods. Clin. Chem. 32, 1593-4.
46. Uchiyama M., Megara M. (1978). Determination of malonaldehyde precursor in tissues by Thiobarbituric acid test. Analy. Biochem. 26, 271-8.
47. Velazquez E., Toumier H. A., Mordujovich de Buschiazzo P., Saavedra G., Schinella G. R. (2003). Antioxidant activity of Paraguayan plant extracts. Fitoterapia. 74(1-2), 91-7.
48. Vinegar L., Schreiber W., Hugo R. (1969). Biphasic development of carrageenan oedema in rats. J. of Pharmco. and Exper. Therap. 166, 96-103.
49. Winter C. A., Risley E. A., Nuss G. W. (1962). Carrageenan-induced oedema in hind paws of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 111: 544-52.
50. Yang Y. C., Lee S. H., Lee W. J., Choi D. H., Ahn Y. J. (2003). Ovicidal and adulticidal effects of Eugenia carophyllata and leave oil compounds on pediculus capitis.J. Agric. Food. Chem 13, 51(17), 4884-8.